NO990722L - Fremgangsmåte for behandling av hjertesvikt - Google Patents
Fremgangsmåte for behandling av hjertesviktInfo
- Publication number
- NO990722L NO990722L NO990722A NO990722A NO990722L NO 990722 L NO990722 L NO 990722L NO 990722 A NO990722 A NO 990722A NO 990722 A NO990722 A NO 990722A NO 990722 L NO990722 L NO 990722L
- Authority
- NO
- Norway
- Prior art keywords
- heart failure
- treatment
- procedure
- phenoxy
- trimethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Denne oppfinnelse vedrører en fremgangsmåte for behandling av et pattedyr som lider av hjertesvikt, omfattende administrering til et pattedyr av en terapeutisk effektiv mengde omfattende 4-(1-etyl-propoksy)-3,6-dimetyl-2-(2,4,6- trimetyl-fenoksy)-pyridinog(3,6-dimetyl-2-(2,4,6-trimetyl-fenoksy)-pyridin-4-yl)-(1- etyl-propyl)-amin eller et farmasøytisk akseptabelt salt derav. Denne oppfinnelse angår også fremgangsmåter for anvendelse av kombinasjoner av disse to midler med andre forbindelser til behandling av kongestiv hjertesvikt for behandling av kongestiv hjertesvikt.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7493498P | 1998-02-17 | 1998-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO990722D0 NO990722D0 (no) | 1999-02-16 |
NO990722L true NO990722L (no) | 1999-08-18 |
Family
ID=22122537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO990722A NO990722L (no) | 1998-02-17 | 1999-02-16 | Fremgangsmåte for behandling av hjertesvikt |
Country Status (28)
Country | Link |
---|---|
US (1) | US6043260A (no) |
EP (1) | EP0951906A1 (no) |
JP (1) | JPH11292766A (no) |
KR (1) | KR19990072616A (no) |
CN (1) | CN1231176A (no) |
AP (1) | AP9901464A0 (no) |
AR (1) | AR017723A1 (no) |
AU (1) | AU1732999A (no) |
BG (1) | BG103180A (no) |
BR (1) | BR9900653A (no) |
CA (1) | CA2262252C (no) |
EA (1) | EA199900124A3 (no) |
GT (1) | GT199900015A (no) |
HR (1) | HRP990054A2 (no) |
HU (1) | HUP9900386A3 (no) |
ID (1) | ID23218A (no) |
IL (1) | IL128531A0 (no) |
IS (1) | IS4975A (no) |
MA (1) | MA26608A1 (no) |
NO (1) | NO990722L (no) |
OA (1) | OA10976A (no) |
PA (1) | PA8467401A1 (no) |
PE (1) | PE20000266A1 (no) |
PL (1) | PL331507A1 (no) |
SG (1) | SG81261A1 (no) |
TN (1) | TNSN99024A1 (no) |
TR (1) | TR199900328A2 (no) |
ZA (1) | ZA991220B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956047B1 (en) | 1995-06-06 | 2005-10-18 | Pfizer Inc. | Corticotropin releasing factor antagonists |
US7125880B1 (en) | 1995-06-06 | 2006-10-24 | Pfizer Inc. | Corticotropin releasing factor antagonists |
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
US6387894B1 (en) * | 1999-06-11 | 2002-05-14 | Pfizer Inc. | Use of CRF antagonists and renin-angiotensin system inhibitors |
CA2382547A1 (en) * | 1999-09-21 | 2001-03-29 | Stephen R. Hanson | Methods and compositions for treating platelet-related disosders |
EA200200688A1 (ru) * | 2000-01-18 | 2003-02-27 | Пфайзер Продактс Инк. | Антагонисты фактора, высвобождающего кортикотропин |
US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
GB0027410D0 (en) * | 2000-11-09 | 2000-12-27 | Pfizer Ltd | Mutual prodrug of amlodipine and atorvastatin |
US6992087B2 (en) | 2001-11-21 | 2006-01-31 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
MXPA04007026A (es) | 2002-02-22 | 2004-10-11 | Pharmacia & Up John Company | Pirimidinonas y pirimidintionas sustituidas. |
JP2005526090A (ja) * | 2002-03-13 | 2005-09-02 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 神経伝達物質調節因子としてのピラゾロ(1,5−a)ピリジン誘導体 |
JP2005533014A (ja) * | 2002-04-26 | 2005-11-04 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 置換ピラジン誘導体 |
AU2003269949A1 (en) * | 2002-09-12 | 2004-04-30 | Pharmacia & Upjohn Company Llc | Substituted 1,4-pyrazine derivatives |
AR041470A1 (es) * | 2002-10-17 | 2005-05-18 | Upjohn Co | Compuestos de pirrolo (1,2 - b) piridazina y sus usos |
BR0315845A (pt) * | 2002-11-21 | 2005-09-27 | Pharmacia & Upjohn Co Llc | Compostos de pirazina como moduladores de crf |
JP2006524223A (ja) * | 2003-04-23 | 2006-10-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Crfアンタゴニストとしての置換されたピリミジノンおよびピリミジンチオン |
EP1622911A2 (en) * | 2003-05-07 | 2006-02-08 | Pharmacia & Upjohn Company LLC | Pyrrolo[1,2-b]pyridazine compounds and their use as crf-1 receptor antagonists |
WO2004099201A1 (en) * | 2003-05-09 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Compounds as crf1 receptor antagonists |
CA2524352A1 (en) * | 2003-05-09 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Substituted pyrimidine derivatives |
MXPA05012087A (es) * | 2003-05-09 | 2006-02-22 | Pharmacia & Upjohn Co Llc | Nuevas pirazinonas como antagonistas del receptor crf1. |
US20050209289A1 (en) * | 2004-03-16 | 2005-09-22 | Talarico Matthew T | Method for vascular dysregulation |
US20060211710A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
US8338441B2 (en) * | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
US6403599B1 (en) * | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
EP0795327A1 (en) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
-
1999
- 1999-01-18 PA PA19998467401A patent/PA8467401A1/es unknown
- 1999-02-02 GT GT199900015A patent/GT199900015A/es unknown
- 1999-02-10 SG SG9900526A patent/SG81261A1/en unknown
- 1999-02-10 US US09/248,073 patent/US6043260A/en not_active Expired - Fee Related
- 1999-02-11 AP APAP/P/1999/001464A patent/AP9901464A0/en unknown
- 1999-02-11 EP EP99301006A patent/EP0951906A1/en not_active Withdrawn
- 1999-02-11 IS IS4975A patent/IS4975A/is unknown
- 1999-02-11 CN CN99102122A patent/CN1231176A/zh active Pending
- 1999-02-12 BR BR9900653-7A patent/BR9900653A/pt not_active Application Discontinuation
- 1999-02-12 PE PE1999000127A patent/PE20000266A1/es not_active Application Discontinuation
- 1999-02-12 KR KR1019990004934A patent/KR19990072616A/ko not_active Application Discontinuation
- 1999-02-15 IL IL12853199A patent/IL128531A0/xx unknown
- 1999-02-15 ID IDP990113D patent/ID23218A/id unknown
- 1999-02-15 CA CA002262252A patent/CA2262252C/en not_active Expired - Fee Related
- 1999-02-16 EA EA199900124A patent/EA199900124A3/ru unknown
- 1999-02-16 NO NO990722A patent/NO990722L/no unknown
- 1999-02-16 BG BG103180A patent/BG103180A/bg unknown
- 1999-02-16 AR ARP990100619A patent/AR017723A1/es unknown
- 1999-02-16 JP JP11037464A patent/JPH11292766A/ja active Pending
- 1999-02-16 TN TNTNSN99024A patent/TNSN99024A1/fr unknown
- 1999-02-16 TR TR1999/00328A patent/TR199900328A2/xx unknown
- 1999-02-16 ZA ZA9901220A patent/ZA991220B/xx unknown
- 1999-02-16 OA OA9900034A patent/OA10976A/en unknown
- 1999-02-16 HU HU9900386A patent/HUP9900386A3/hu unknown
- 1999-02-16 MA MA25465A patent/MA26608A1/fr unknown
- 1999-02-16 AU AU17329/99A patent/AU1732999A/en not_active Abandoned
- 1999-02-17 HR HR60/074,934A patent/HRP990054A2/hr not_active Application Discontinuation
- 1999-02-17 PL PL99331507A patent/PL331507A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2262252C (en) | 2006-01-10 |
AU1732999A (en) | 1999-09-02 |
HUP9900386A3 (en) | 1999-12-28 |
HUP9900386A2 (hu) | 1999-11-29 |
TR199900328A2 (xx) | 1999-10-21 |
PE20000266A1 (es) | 2000-04-07 |
EA199900124A3 (ru) | 1999-12-29 |
AR017723A1 (es) | 2001-09-12 |
MA26608A1 (fr) | 2004-12-20 |
NO990722D0 (no) | 1999-02-16 |
HRP990054A2 (en) | 2000-02-29 |
PL331507A1 (en) | 1999-08-30 |
GT199900015A (es) | 2000-07-26 |
EP0951906A1 (en) | 1999-10-27 |
BR9900653A (pt) | 2000-10-17 |
CN1231176A (zh) | 1999-10-13 |
ZA991220B (en) | 2000-08-16 |
IS4975A (is) | 1999-08-18 |
AP9901464A0 (en) | 1999-03-31 |
KR19990072616A (ko) | 1999-09-27 |
IL128531A0 (en) | 2000-01-31 |
BG103180A (bg) | 1999-09-30 |
OA10976A (en) | 2001-11-05 |
JPH11292766A (ja) | 1999-10-26 |
US6043260A (en) | 2000-03-28 |
CA2262252A1 (en) | 1999-08-17 |
SG81261A1 (en) | 2001-06-19 |
PA8467401A1 (es) | 2000-09-29 |
ID23218A (id) | 2000-03-30 |
TNSN99024A1 (fr) | 2005-11-10 |
HU9900386D0 (en) | 1999-04-28 |
EA199900124A2 (ru) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO990722L (no) | Fremgangsmåte for behandling av hjertesvikt | |
MD970253A (ro) | Inhibitori biciclici micromoleculari ai trombinei | |
UA66865C2 (uk) | Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти) | |
DK0966447T3 (da) | Anvendelige små molekyler til behandling af betændelsessygdomme | |
WO2003057225A3 (en) | Phosphate transport inhibitors | |
DK0813525T3 (da) | Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter | |
NO872863D0 (no) | Analogifremgangsmaate for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-ii-reseptorer. | |
DK0923570T3 (da) | Pyridylalken- og pyridylalkynsyreamider som cytostatiske og immunosuppresive midler | |
DK1107794T3 (da) | Terapeutiske præparater til behandling af mucus-hypersekretion | |
EA200401160A1 (ru) | Производные тиазола и оксазола, которые модулируют активность ppar | |
MXPA03006855A (es) | Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion. | |
EA200200194A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
EA200301276A1 (ru) | Новые производные сульфоновых кислот | |
DK1066056T4 (da) | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et... | |
FI103111B1 (fi) | Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi | |
DK0888271T3 (da) | Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler | |
ATE273279T1 (de) | 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2 | |
NO20051390L (no) | Fremgangsmate for behandling av pasienter med massivt blodtap | |
AU551066B2 (en) | Pyridyl substituted pyridylalkyleneamino pyrimidones | |
DK0556322T3 (da) | Aminosulfonylurinstof-ACAT-inhibitorer | |
DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
EA199800889A1 (ru) | Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция | |
EA200101205A1 (ru) | Применение комбинации витаминов для лечения зуда и неинфекционных заболеваний, приводящих к зуду и/или воспалению | |
DK1152760T3 (da) | Anvendelse af 4-aminopyridin til behandling af perifere neuropatier | |
ES534452A0 (es) | Un procedimiento para preparar un derivado de primidona |